- Home
- BMY vs TDG Comparison
BMY vs TDG Comparison
Compare BMY & TDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMY
- TDG
- Stock Information
- Founded
- BMY 1887
- TDG 1993
- Country
- BMY United States
- TDG United States
- Employees
- BMY N/A
- TDG N/A
- Industry
- BMY Biotechnology: Pharmaceutical Preparations
- TDG Military/Government/Technical
- Sector
- BMY Health Care
- TDG Industrials
- Exchange
- BMY Nasdaq
- TDG Nasdaq
- Market Cap
- BMY 94.0B
- TDG 78.3B
- IPO Year
- BMY N/A
- TDG 2006
- Fundamental
- Price
- BMY $46.15
- TDG $1,276.14
- Analyst Decision
- BMY Hold
- TDG Buy
- Analyst Count
- BMY 15
- TDG 14
- Target Price
- BMY $57.64
- TDG $1,606.86
- AVG Volume (30 Days)
- BMY 9.8M
- TDG 369.5K
- Earning Date
- BMY 10-30-2025
- TDG 11-06-2025
- Dividend Yield
- BMY 5.37%
- TDG 5.89%
- EPS Growth
- BMY N/A
- TDG 11.52
- EPS
- BMY 2.49
- TDG 30.14
- Revenue
- BMY $47,704,000,000.00
- TDG $8,580,000,000.00
- Revenue This Year
- BMY N/A
- TDG $11.94
- Revenue Next Year
- BMY N/A
- TDG $9.99
- P/E Ratio
- BMY $18.59
- TDG $42.26
- Revenue Growth
- BMY 2.57
- TDG 12.81
- 52 Week Low
- BMY $42.96
- TDG $1,183.60
- 52 Week High
- BMY $63.33
- TDG $1,623.83
- Technical
- Relative Strength Index (RSI)
- BMY 42.96
- TDG 33.82
- Support Level
- BMY $46.00
- TDG $1,269.32
- Resistance Level
- BMY $46.84
- TDG $1,304.32
- Average True Range (ATR)
- BMY 0.93
- TDG 29.06
- MACD
- BMY -0.14
- TDG 1.16
- Stochastic Oscillator
- BMY 11.28
- TDG 19.29
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About TDG Transdigm Group Incorporated
TransDigm manufactures and services a broad set of specialized parts for commercial and military aircraft. The firm organizes itself in three segments: power and control, airframes, and a small non-aviation segment, which serves mostly off-road vehicles and mining equipment. It operates as an acquisitive holding company that focuses its portfolio on firms that make proprietary aerospace products with substantial aftermarket demand. TransDigm regularly employs financial leverage to amplify its operating results.